California Public Employees Retirement System Fate Therapeutics Inc Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$9.86 - $23.83 $171,583 - $414,689	-17,402 Reduced 9.88%	158,802 $1.6 Million
Q3 2022 Nov 09, 2022	BUY	$21.04 - $36.06 $796,490 - $1.37 Million	37,856 Added 27.36%	176,204 $3.95 Million
Q1 2022 May 04, 2022	SELL	$29.67 - $60.28 $670,452 - $1.36 Million	-22,597 Reduced 14.04%	138,348 $5.36 Million
Q4 2021 Feb 10, 2022	SELL	$47.84 - $64.34 $980,815 - $1.32 Million	-20,502 Reduced 11.3%	160,945 $9.42 Million
Q3 2021 Nov 10, 2021	BUY	$59.27 - $95.73 $161,332 - $260,577	2,722 Added 1.52%	181,447 $10.8 Million
Q2 2021 Aug 13, 2021	SELL	$67.25 - $92.52 $131,272 - $180,599	-1,952 Reduced 1.08%	178,725 $15.5 Million
Q1 2021 May 14, 2021	BUY	$72.16 - $117.4 $562,126 - $914,546	7,790 Added 4.51%	180,677 $14.9 Million
Q4 2020 Feb 02, 2021	BUY	$38.09 - $100.95 $411,638 - $1.09 Million	10,807 Added 6.67%	172,887 $15.7 Million
Q3 2020 Nov 05, 2020	BUY	$30.41 - $40.5 $716,459 - $954,180	23,560 Added 17.01%	162,080 $6.48 Million
Q2 2020 Aug 12, 2020	BUY	$20.21 - $35.23 $68,188 - $118,866	3,374 Added 2.5%	138,520 $4.75 Million
Q1 2020 May 12, 2020	BUY	$17.28 - $31.88 $193,726 - $357,406	11,211 Added 9.05%	135,146 $3 Million
Q4 2019 Jan 27, 2020	SELL	$13.39 - $20.73 $388,028 - $600,734	-28,979 Reduced 18.95%	123,935 $2.43 Million
Q3 2019 Oct 31, 2019	BUY	$15.47 - $22.5 $1.43 Million - $2.08 Million	92,628 Added 153.65%	152,914 $2.38 Million
Q2 2019 Aug 15, 2019	BUY	$15.61 - $20.44 $85,386 - $111,806	5,470 Added 9.98%	60,286 $1.22 Million
Q1 2019 May 03, 2019	SELL	$13.15 - $18.71 $44,289 - $63,015	-3,368 Reduced 5.79%	54,816 $963,000
Q3 2018 Nov 13, 2018	BUY	$8.75 - $16.29 $360,421 - $671,001	41,191 Added 242.4%	58,184 $948,000
Q2 2018 Aug 15, 2018	BUY	$9.16 - $13.48 $155,655 - $229,065	16,993 New	16,993 $193,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $222M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account